Verrica Pharmaceuticals I...

0.66
0.01 (1.68%)
At close: Mar 03, 2025, 3:59 PM
0.64
-2.54%
After-hours: Mar 03, 2025, 04:00 PM EST

Verrica Pharmaceuticals Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Cash & Equivalents 69.55M 34.27M 15.75M 10.69M 9.24M 89.81M 8.66M 527K
Short-Term Investments n/a n/a 54.6M 54.78M 52.78M 79.54M n/a n/a
Long-Term Investments n/a n/a n/a n/a 410K n/a n/a n/a
Other Long-Term Assets 452K n/a n/a 3.75M 830K 1.84M n/a n/a
Receivables 4.42M 487K n/a n/a n/a n/a n/a n/a
Inventory 1.02M -487K n/a n/a n/a n/a n/a n/a
Other Current Assets 2.54M 8.71M 7.95M 4.36M 5.93M 2.69M 420K 17K
Total Current Assets 77.53M 39.12M 74.33M 65.47M 64.98M 89.81M 9.08M 544K
Property-Plant & Equipment 3.62M 5.61M 5.8M 4.94M 2.2M 255K n/a n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 4.07M 5.61M 5.8M 8.68M 3.44M 2.1M n/a n/a
Total Assets 81.6M 44.72M 80.13M 74.15M 68.42M 91.91M 9.08M 544K
Account Payables 2.46M 507K 845K 348K 1.19M 922K 153K 67K
Deferred Revenue n/a n/a n/a 500K n/a n/a n/a -36K
Short-Term Debt 700K 594K 41.94M 35.71M 260K n/a n/a n/a
Other Current Liabilities 13.86M 2.36M 3.27M 2.92M 1.91M 1.55M 463K 352K
Total Current Liabilities 17.02M 3.46M 46.05M 39.48M 3.35M 2.48M 616K 419K
Long-Term Debt 44.81M 1.23M 1.47M 1.69M 58K n/a n/a n/a
Other Long-Term Liabilities n/a n/a n/a n/a n/a n/a n/a 2.79M
Total Long-Term Liabilities 44.81M 1.23M 1.47M 35.31M 58K n/a n/a 2.79M
Total Liabilities 61.83M 4.69M 47.52M 41.17M 3.41M 2.48M 616K 3.21M
Total Debt 45.51M 1.53M 43.41M 35.31M 188K n/a n/a 36K
Common Stock 4K 4K 3K 3K 3K 3K 2K 1K
Retained Earnings -230.45M -163.45M -138.97M -103.89M -61.19M -33.08M -12.44M -2.68M
Comprehensive Income n/a n/a -29K 1K 20K -17K -15.51M -1K
Shareholders Equity 19.76M 40.03M 32.6M 32.99M 65.02M 89.43M 8.47M -2.66M
Total Investments n/a n/a 54.6M 54.78M 52.78M 79.54M n/a n/a